Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    October 2017
  1. GREEN AJ, Gelfand JM, Cree BA, Bevan C, et al
    Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32346.
    PubMed     Text format     Abstract available


  2. RUBIN R
    Mary Crow: leader in research on systemic lupus erythematosus.
    Lancet. 2017;390:1636.
    PubMed     Text format    


    March 2017
  3. WYATT RJ
    Are we ready for targeted therapy for IgA nephropathy?
    Lancet. 2017 Mar 28. pii: S0140-6736(17)30820.
    PubMed     Text format    


  4. FELLSTROM BC, Barratt J, Cook H, Coppo R, et al
    Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.
    Lancet. 2017 Mar 28. pii: S0140-6736(17)30550.
    PubMed     Text format     Abstract available


  5. ATKINS H, Freedman MS
    Immunoablation and aHSCT for aggressive multiple sclerosis - Authors' reply.
    Lancet. 2017;389:908.
    PubMed     Text format    


  6. HARRIS M, Cossburn M, Gregory R
    Immunoablation and aHSCT for aggressive multiple sclerosis.
    Lancet. 2017;389:907-908.
    PubMed     Text format    


    January 2017
  7. BUENZ EJ, Parry GJ, Ranta A
    Guillain-Barre syndrome: surveillance and cost of treatment strategies.
    Lancet. 2017;389:253.
    PubMed     Text format    


  8. WILLISON HJ, Jacobs BC, van Doorn PA
    Guillain-Barre syndrome: surveillance and cost of treatment strategies - Authors' reply.
    Lancet. 2017;389:253-254.
    PubMed     Text format    


  9. DURRHEIM DN
    Guillain-Barre syndrome: surveillance and cost of treatment strategies.
    Lancet. 2017;389:252-253.
    PubMed     Text format    


  10. CHEN H, Kwong JC, Copes R, Tu K, et al
    Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study.
    Lancet. 2017 Jan 4. pii: S0140-6736(16)32399.
    PubMed     Text format     Abstract available


    November 2016
  11. COMI G, Radaelli M, Soelberg Sorensen P
    Evolving concepts in the treatment of relapsing multiple sclerosis.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)32388.
    PubMed     Text format     Abstract available


  12. ONTANEDA D, Thompson AJ, Fox RJ, Cohen JA, et al
    Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)31320.
    PubMed     Text format     Abstract available


  13. BROWNLEE WJ, Hardy TA, Fazekas F, Miller DH, et al
    Diagnosis of multiple sclerosis: progress and challenges.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)30959.
    PubMed     Text format     Abstract available


    September 2016
  14. BOLINDER J, Antuna R, Geelhoed-Duijvestijn P, Kroger J, et al
    Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
    Lancet. 2016 Sep 9. pii: S0140-6736(16)31535.
    PubMed     Text format     Abstract available


    July 2016
  15. LAZARUS C, Guichard M, Philippe JM, Paux T, et al
    The French experience of the threat posed by Zika virus.
    Lancet. 2016;388:9-11.
    PubMed     Text format    


  16. TARANTINO MD, Bussel JB, Blanchette VS, Despotovic J, et al
    Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study.
    Lancet. 2016;388:45-54.
    PubMed     Text format     Abstract available


  17. CHATURVEDI S, McCrae KR
    Treatment of chronic immune thrombocytopenia in children with romiplostim.
    Lancet. 2016;388:4-6.
    PubMed     Text format    


    June 2016
  18. FONTANET A, Cao-Lormeau VM, Dub T, Mallet HP, et al
    Association between Guillain-Barre syndrome and Zika virus infection - Authors' reply.
    Lancet. 2016;387:2600.
    PubMed     Text format    


  19. BAUTISTA LE, Sethi AK
    Association between Guillain-Barre syndrome and Zika virus infection.
    Lancet. 2016;387:2599-600.
    PubMed     Text format    


  20. AVELINO-SILVA VI, Martin JN
    Association between Guillain-Barre syndrome and Zika virus infection.
    Lancet. 2016;387:2599.
    PubMed     Text format    


  21. RUPERTO N, Pistorio A, Ravelli A, Angioloni S, et al
    The PRINTO juvenile dermatomyositis trial - Authors' reply.
    Lancet. 2016;387:2601.
    PubMed     Text format    


  22. DALE A, Milosevic I, Goldacre B
    The PRINTO juvenile dermatomyositis trial.
    Lancet. 2016;387:2600-1.
    PubMed     Text format    


  23. ATKINS HL, Bowman M, Allan D, Anstee G, et al
    Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
    Lancet. 2016 Jun 8. pii: S0140-6736(16)30169.
    PubMed     Text format     Abstract available


  24. DORR J
    Haemopoietic stem-cell transplantation for multiple sclerosis: what next?
    Lancet. 2016 Jun 8. pii: S0140-6736(16)30377.
    PubMed     Text format    


  25. ZOMA AA
    Clinical overlap in proximal artery stenosis: two disorders or one?
    Lancet. 2016;387:2350.
    PubMed     Text format    


  26. JAIN P, Ruchin P, Suttie J
    Proximal pulmonary artery stenosis: a rare manifestation of granulomatosis with polyangiitis.
    Lancet. 2016;387:2349-50.
    PubMed     Text format    


  27. REWERS M, Ludvigsson J
    Environmental risk factors for type 1 diabetes.
    Lancet. 2016;387:2340-8.
    PubMed     Text format     Abstract available


  28. POCIOT F, Lernmark A
    Genetic risk factors for type 1 diabetes.
    Lancet. 2016;387:2331-9.
    PubMed     Text format     Abstract available


  29. RUBIN R
    Kevan Herold: untangling type 1 diabetes in the clinic and the lab.
    Lancet. 2016;387:2283.
    PubMed     Text format    


  30. RUBIN R
    Profile: Type 1 Diabetes TrialNet.
    Lancet. 2016;387:2280.
    PubMed     Text format    



  31. Towards a better understanding of type 1 diabetes.
    Lancet. 2016;387:2264.
    PubMed     Text format    


    May 2016
  32. FLOEGE J, Amann K
    Primary glomerulonephritides.
    Lancet. 2016;387:2036-48.
    PubMed     Text format     Abstract available


  33. GUILLEVIN L, Regent A
    Treating giant-cell arteritis: is IL-6 the cytokine to target?
    Lancet. 2016;387:1882-1883.
    PubMed     Text format    


    April 2016
  34. BARNETT R
    Systemic lupus erythematosus.
    Lancet. 2016;387:1711.
    PubMed     Text format    


  35. BRASIL P, Sequeira PC, Freitas AD, Zogbi HE, et al
    Guillain-Barre syndrome associated with Zika virus infection.
    Lancet. 2016;387:1482.
    PubMed     Text format    


  36. SNYDER A
    John Kurtzke.
    Lancet. 2016;387:1370.
    PubMed     Text format    


    March 2016
  37. DE LEO S, Lee SY, Braverman LE
    Hyperthyroidism.
    Lancet. 2016 Mar 30. pii: S0140-6736(16)00278.
    PubMed     Text format     Abstract available


  38. VILLIGER PM, Adler S, Kuchen S, Wermelinger F, et al
    Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
    Lancet. 2016 Mar 4. pii: S0140-6736(16)00560.
    PubMed     Text format     Abstract available


  39. MECHARLES S, Herrmann C, Poullain P, Tran TH, et al
    Acute myelitis due to Zika virus infection.
    Lancet. 2016 Mar 3. pii: S0140-6736(16)00644.
    PubMed     Text format    


    February 2016
  40. WILLISON HJ, Jacobs BC, van Doorn PA
    Guillain-Barre syndrome.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00339.
    PubMed     Text format     Abstract available


  41. CAO-LORMEAU VM, Blake A, Mons S, Lastere S, et al
    Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00562.
    PubMed     Text format     Abstract available


  42. SMITH DW, Mackenzie J
    Zika virus and Guillain-Barre syndrome: another viral cause to add to the list.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00564.
    PubMed     Text format    


  43. SARGENT J
    Rheumatology--a call for papers.
    Lancet. 2016;387:519.
    PubMed     Text format    


    January 2016
  44. SEGAL BM, Stuve O
    Primary progressive multiple sclerosis-why we are failing.
    Lancet. 2016 Jan 27. pii: S0140-6736(16)00158.
    PubMed     Text format    


  45. LUBLIN F, Miller DH, Freedman MS, Cree BA, et al
    Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.
    Lancet. 2016 Jan 27. pii: S0140-6736(15)01314.
    PubMed     Text format     Abstract available


  46. MILOSEVIC I, Slade E, Drysdale H
    Eltrombopag for chronic immune thrombocytopenia.
    Lancet. 2016;387:336.
    PubMed     Text format    


  47. GRAINGER JD
    Eltrombopag for chronic immune thrombocytopenia - Authors' reply.
    Lancet. 2016;387:336-7.
    PubMed     Text format    


    December 2015
  48. FEEHALLY J
    Glomerulonephritis from a chronically infected implanted device.
    Lancet. 2015;386:2364.
    PubMed     Text format    


  49. SARITAS T, Brandenburg V, Federico G, Grone HJ, et al
    Glomerulonephritis triggered by a chronically infected left ventricular assist device.
    Lancet. 2015;386:2363-4.
    PubMed     Text format    


    November 2015
  50. MIOSSEC P
    Progress in the treatment of juvenile dermatomyositis.
    Lancet. 2015 Nov 27. pii: S0140-6736(15)01023.
    PubMed     Text format    


  51. RUPERTO N, Pistorio A, Oliveira S, Zulian F, et al
    Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.
    Lancet. 2015 Nov 27. pii: S0140-6736(15)01021.
    PubMed     Text format     Abstract available


  52. DHALIWAL HS, Sekhon GS, Rai N, Nampoothiri RV, et al
    An unusual medical cause of abdominal pain diagnosed by urological abnormalities.
    Lancet. 2015 Nov 13. pii: S0140-6736(15)00806.
    PubMed     Text format    


  53. LOCKWOOD DN, Lambert SM, Walker SL
    Cutaneous nodules with positive autoantibodies: diagnostic pitfalls.
    Lancet. 2015;386:1916.
    PubMed     Text format    


  54. ZHANG G, Jin H, Chen H, Lu Q, et al
    Cutaneous nodules with positive autoantibodies: histoid leprosy.
    Lancet. 2015;386:1915-6.
    PubMed     Text format    


    October 2015
  55. KIPFER S, Frigerio S, Hench J, Aussy A, et al
    Immune-mediated necrotising myopathy linked to statin use.
    Lancet. 2015;386:e26.
    PubMed     Text format    


  56. NEUNERT CE, Grace RF
    Thrombopoietin-receptor agonists in children with immune thrombocytopenia.
    Lancet. 2015;386:1606-9.
    PubMed     Text format    


  57. GRAINGER JD, Locatelli F, Chotsampancharoen T, Donyush E, et al
    Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
    Lancet. 2015;386:1649-58.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: